For Healthcare Professionals - International

CoreValve OUS

TAVI Platform

CoreValve ADVANCE Study

ADVANCE is a rigorous, fully monitored study of TAVI in the "real world." 1,015 patients intended to be treated with the Medtronic CoreValve System were enrolled at 44 centers (in 12 countries worldwide).

  • All ECGs and procedural angiograms were assessed by a core lab.
  • All primary endpoints were adjudicated by an independent Clinical Event Committee.
  • All cerebrovascular events were adjudicated by an independent neurologist.

Clinical endpoints reported according to Valve Academic Research Consortium (VARC).

evolut-page-divider

evolut-advance-study-1

evolut-page-divider

evolut-advance-study-2

evolut-page-divider

evolut-advance-study-3

evolut-page-divider

evolut-advance-study-data-4

Performance That Matters